Funded projects
The following projects were funded by the Medical and Life Sciences Translational Fund in November 2025:
- Neuraminidases as novel therapeutic targets for neurodegenerative diseases - Platt, Frances M (Pharmacology, MSD)
- A Novel Gene Therapy Approach for Leber Hereditary Optic Neuropathy - Kapetanovic, Jasmina (NDCN, MSD)
- Faster Oxygen Saturation Measurements for Paediatric Assessment - Hayward, Gail (Primary Care Health Sciences, MSD)
- Clinical feasibility study of a rapid, point-of-care urinary test for detecting intravascular haemolysis - Swietach, Pawel (DPAG, MSD)
- Novel bispecific therapeutics for breast cancer - Drakesmith, Alexander (RDM, MSD)
- Using the hypoxic response for cancer treatment - Schofield, Christopher (Chemistry Department, MPLS)
- Expanding the applicability of a novel injectable long-acting formulation platform - Stevens, Molly (DPAG, MSD)
- Trustworthy Transfer of Biosignal Foundation Models across Healthcare Settings - Gu, Xiao (Engineering Science, MPLS)
- Validating the Oxford Cognitive Screen-Plus for Cognitive Impairment After Traumatic Brain Injury (OCS+ ABI) - Demeyere, Nele (NDCN, MSD)
- From AI-ECG Phenotyping to Patient Impact: Translating High Afterload ECG Signatures into Cardiovascular Risk Stratification for Acute Care - Raman, Betty (RDM, MSD)
- SpeechMate: AI-powered fluency enhancer app for stutter-free public speaking - Denison, Timothy (Engineering Science, MPLS)
- Nanoparticle-mediated immunotherapy for severe asthma and treatment-resistant cohorts to widen global access - Hill, Adrian (NDM, MSD)
- Noetic: From Story to Structure - Validating a Safe AI System for Chronic Pain Care - Seymour, Benjamin (NDCN, MSD)
- Commercialisation Landscape & Partnering Strategy for MRC CoRE: Blood Resilience (delivered by Wellspring) - Mead, Adam (RDM, MSD)
- Novel binders to MPOX antigens: overcoming the diagnostic sensitivity limit - Adams, Emily (NDM, MSD)
